Skip to main content
Enter your keywords
User account menu
Log in
Main navigation
About
History & Impact
Mission & Values
Leadership
Support SWOG
Join SWOG
Policies & Procedures
Careers
Contact Us
The SWOG Network
How We Work
Our Staff
Our Advocates
Our Partners
News & Events
News
SWOG Stories
SWOG Meetings
For Press
Clinical Trials
Biospecimen Submission
Biospecimen Access
Clinical Trials Search
Clinical Research Resources
Frequently Asked Questions
Publications
Institutions
Quality Assurance & Audits
Serious Adverse Events
Training Resources
CRA Workbench
Protocol Workbench
For Patients
Patient & Advocate Voices
Trials Open to Patients
About SWOG Cancer Trials
Joining a Trial
Glossary
Breadcrumb
SWOG
Clinical Trials
SWOG-8752
SWOG clinical trial number
SWOG-8752
A Phase II Study of Recombinant Tumor Necrosis (rTNF) in Patients with Endometrial Cancer
Closed
Phase
Accrual
17%
Abbreviated Title
A Phase II Study of Recombinant Tumor Necrosis (rTNF) in Patients with Endometrial Cancer
Activated
09/15/1988
Closed
07/15/1990
